… that ATP terminates 78% to 94% of ventricular tachycardias (VTs) <188 to 200 bpm with a
2… shocks for safety and QoL was not performed. This trial examined the efficacy, safety, and …

… In this trial, we assessed the safety and efficacy of STAR in patients with ventricular
tachycardia (VT), focusing on early treatment-related grade ≥ 3 adverse events (AE). …

… of ventricular tachycardia: Twenty monomorphic VTs were induced in the 18 patients in
this study. Sixteen patients had 1 morphology of VT, and 2 patients had 2 morphologies. The …

… ventricular tachycardia cardioversion by implantable cardioverter/defibrillators. We compared
the efficacy and safety of … Twelve patients with sustained ventricular tachycardia and heart …

… efficacy, and in particular the safety/tolerance, of d-sotalol with respect to the management
of ventricular tachycardia … left ventricular ejection fraction (LVEF). In these patients, d-sotalol …

… However, evaluating drug efficacy was not the primary purpose of the study, and efficacy
compared with placebo was not measured. A multicentre, double-blind, randomised study27 …

… Optimal timing for catheter ablation of ventricular tachycardia is an important unresolved
issue. There are no randomized trials evaluating the benefit of ablation after the first implantable …

… Single-session cardiac stereotactic radiation therapy (SBRT) has demonstrated promising
results for patients with refractory ventricular tachycardia (VT). However, the full safety profile …

… Catheter ablation is currently an effective strategy in the treatment of incessant ventricular
tachycardia (VT) and to reduce or prevent recurrent, symptomatic, drug-refractory episodes of …

… Background Implantable cardioverter-defibrillators (ICDs) can terminate some ventricular
tachycardias (VTs) painlessly with antitachycardia pacing (ATP). ATP has not routinely been …